1. Home
  2. RCAT vs GLUE Comparison

RCAT vs GLUE Comparison

Compare RCAT & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$8.26

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$14.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
GLUE
Founded
2002
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
RCAT
GLUE
Price
$8.26
$14.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$20.00
$32.00
AVG Volume (30 Days)
8.7M
1.2M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
$123,672,000.00
Revenue This Year
$271.60
N/A
Revenue Next Year
$41.21
$2.45
P/E Ratio
N/A
$72.42
Revenue Growth
79.95
63.54
52 Week Low
$5.77
$4.79
52 Week High
$18.78
$25.77

Technical Indicators

Market Signals
Indicator
RCAT
GLUE
Relative Strength Index (RSI) 40.90 36.40
Support Level $7.16 N/A
Resistance Level $8.85 $16.66
Average True Range (ATR) 0.63 0.72
MACD -0.17 0.11
Stochastic Oscillator 1.69 34.19

Price Performance

Historical Comparison
RCAT
GLUE

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Share on Social Networks: